British Journal of Ophthalmology · 2009 · 65 citations · 21 references
MedicineOphthalmologyPharmacotherapyClinical Vision ScienceOcular PharmacologyOphthalmic SurgeryDiabetic RetinopathyRetinal PharmacotherapyRetinal SurgeryRetinal Vascular DiseaseClinical Trial Efficacy EndpointsDiabetic Retinopathy TherapyDiabetic Retinopathy Vision LossFoveal ThicknessLaser PhotocoagulationPrimary Efficacy EndpointsRetinal PhotocoagulationSecondary Efficacy Endpoints
BACKGROUND: To compare the efficacy of intravitreal pegaptanib (IVP) with panretinal laser photocoagulation (PRP) in the treatment of active proliferative diabetic retinopathy (PDR). METHODS: A prospective, randomised, controlled, open-label, exploratory study. Twenty subjects with active PDR were randomly assigned at a 1:1 ratio to receive treatment in one eye either with IVP (0.3 mg) every 6 weeks for 30 weeks or with PRP laser. Efficacy endpoints included regression of retinal neovascularisation (NV), changes from baseline in best-corrected visual acuity (BCVA) and foveal thickness. Safety outcomes included observed and reported adverse events. RESULTS: In 90% of randomised eyes to IVP, retinal NV showed regression by week 3. By week 12, all IVP eyes were completely regressed and maintained through week 36. In the PRP-treated group, at week 36, two eyes demonstrated complete regression, two showed partial regression, and four showed persistent active PDR. The mean change in BCVA at 36 weeks was +5.8 letters in pegaptanib-treated eyes and -6.0 letters in PRP-treated eyes. Only mild to moderate transient ocular adverse events were reported with pegaptanib. CONCLUSIONS: IVP produces short-term marked and rapid regression of diabetic retinal NV. Regression of NV was maintained throughout the study and at the final visit.
21
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
David W. M. Leung, George Cachianes, Wun-Jing Kuang et al. · Science · 1989 · 5K citations
Global data on visual impairment in the year 2002.
Serge Resnikoff, Donatella Pascolini, Daniel Etya’ale et al. · PubMed · 2004 · 4.2K citations
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Pamela J. Keck, Scott D. Hauser, Gwen G. Krivi et al. · Science · 1989 · 2.1K citations
The Prevalence of Diabetic Retinopathy Among Adults in the United States
John H. Kempen, O'Colmain Bj, Leske Mc et al. · Archives of Ophthalmology · 2004 · 1.1K citations
Medicine, Ophthalmology, Diabetology +14